MedCap AB's market value is the price at which a share of MedCap AB trades on a public exchange. It measures the collective expectations of MedCap AB investors about its performance. MedCap AB is selling for under 489.50 as of the 1st of March 2026; that is 1.56% up since the beginning of the trading day. The stock's last reported lowest price was 476.5. With this module, you can estimate the performance of a buy and hold strategy of MedCap AB and determine expected loss or profit from investing in MedCap AB over a given investment horizon. Check out MedCap AB Correlation, MedCap AB Volatility and MedCap AB Performance module to complement your research on MedCap AB.
Understanding that MedCap AB's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MedCap AB represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MedCap AB's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
MedCap AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedCap AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedCap AB.
0.00
12/01/2025
No Change 0.00
0.0
In 2 months and 31 days
03/01/2026
0.00
If you would invest 0.00 in MedCap AB on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding MedCap AB or generate 0.0% return on investment in MedCap AB over 90 days. MedCap AB is related to or competes with Creades AB, Ratos AB, Hoist Finance, Investment, Svolder AB, AB Traction, and CoinShares International. MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation,... More
MedCap AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedCap AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedCap AB upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedCap AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedCap AB's standard deviation. In reality, there are many statistical measures that can use MedCap AB historical prices to predict the future MedCap AB's volatility.
MedCap AB has Sharpe Ratio of -0.0733, which conveys that the firm had a -0.0733 % return per unit of risk over the last 3 months. MedCap AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MedCap AB's Mean Deviation of 1.71, risk adjusted performance of (0.04), and Standard Deviation of 2.31 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.46, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning MedCap AB are expected to decrease at a much lower rate. During the bear market, MedCap AB is likely to outperform the market. At this point, MedCap AB has a negative expected return of -0.18%. Please make sure to verify MedCap AB's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if MedCap AB performance from the past will be repeated at some point in the near future.
Auto-correlation
0.09
Virtually no predictability
MedCap AB has virtually no predictability. Overlapping area represents the amount of predictability between MedCap AB time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MedCap AB price movement. The serial correlation of 0.09 indicates that less than 9.0% of current MedCap AB price fluctuation can be explain by its past prices.
Correlation Coefficient
0.09
Spearman Rank Test
0.04
Residual Average
0.0
Price Variance
435.84
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.